BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27403784)

  • 1. Buprenorphine implants (Probuphine) for opioid dependence.
    Med Lett Drugs Ther; 2016 Jul; 58(1499):94-5. PubMed ID: 27403784
    [No Abstract]   [Full Text] [Related]  

  • 2. Once-monthly subcutaneous buprenorphine (Sublocade) for opioid use disorder.
    Med Lett Drugs Ther; 2018 Feb; 60(1541):35-37. PubMed ID: 29485976
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic interactions between darunavir/ritonavir and opioid maintenance therapy using methadone or buprenorphine/naloxone.
    Sekar V; Tomaka F; Lefebvre E; De Pauw M; Vangeneugden T; van den Brink W; Hoetelmans R
    J Clin Pharmacol; 2011 Feb; 51(2):271-8. PubMed ID: 20421512
    [No Abstract]   [Full Text] [Related]  

  • 4. The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia.
    Horyniak D; Dietze P; Larance B; Winstock A; Degenhardt L
    Int J Drug Policy; 2011 Mar; 22(2):167-71. PubMed ID: 21112758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New drugs for substitution treatment of opioid dependence. Buprenorphine and 1-alpha-acetylmethadol (LAAM) ].
    Petersen H; Skauge L; Svejsø J; Ege PP
    Ugeskr Laeger; 2000 Nov; 162(48):6553-6. PubMed ID: 11187226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting.
    Pélissier F; Rougé Bugat ME; Nubukpo P; Franchitto N
    J Clin Psychopharmacol; 2016 Feb; 36(1):100-3. PubMed ID: 26658085
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology Update: Probuphine: The Long-Acting Buprenorphine Implant.
    Lorman WJ
    J Addict Nurs; 2019; 30(2):123-124. PubMed ID: 31162216
    [No Abstract]   [Full Text] [Related]  

  • 8. Case Series of Successful Postoperative Pain Management in Buprenorphine Maintenance Therapy Patients.
    Leighton BL; Crock LW
    Anesth Analg; 2017 Nov; 125(5):1779-1783. PubMed ID: 29049122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine implants in medical treatment of opioid addiction.
    Chavoustie S; Frost M; Snyder O; Owen J; Darwish M; Dammerman R; Sanjurjo V
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):799-807. PubMed ID: 28571505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine maintenance therapy hinders acute pain management in trauma.
    Harrington CJ; Zaydfudim V
    Am Surg; 2010 Apr; 76(4):397-9. PubMed ID: 20420250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable Buprenorphine (Probuphine) for Maintenance Treatment of Opioid Use Disorder.
    Goodbar NH; Hanlon KE
    Am Fam Physician; 2018 May; 97(10):668-670. PubMed ID: 29763278
    [No Abstract]   [Full Text] [Related]  

  • 12. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
    Cottrill CB; Matson SC
    Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
    [No Abstract]   [Full Text] [Related]  

  • 13. Medications for Opioid Use Disorder: A Guide for Physicians.
    Azhar N; Chockalingam R; Azhar A
    Mo Med; 2020; 117(1):59-64. PubMed ID: 32158052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Livedo-like dermatitis and necrotic lesions after high-dose buprenorphine injections: a national French survey.
    Wainstein L; Bernier C; Gérardin M; Bouquié R; Espitia O; Mussini JM; Jolliet P; Victorri-Vigneau C
    Br J Dermatol; 2015; 172(5):1412-4. PubMed ID: 25353069
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of Pharmacological Treatments for Opioid Use Disorder on Mortality.
    Kelty E; Hulse G; Joyce D; Preen DB
    CNS Drugs; 2020 Jun; 34(6):629-642. PubMed ID: 32215842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence.
    Orman JS; Keating GM
    Drugs; 2009; 69(5):577-607. PubMed ID: 19368419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single high-dose buprenorphine for opioid craving during withdrawal.
    Ahmadi J; Jahromi MS; Ghahremani D; London ED
    Trials; 2018 Dec; 19(1):675. PubMed ID: 30526648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in managing opioid addiction: impact of a subdermal buprenorphine implant.
    Itzoe M; Guarnieri M
    Drug Des Devel Ther; 2017; 11():1429-1437. PubMed ID: 28546740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine.
    Tompkins DA; Smith MT; Mintzer MZ; Campbell CM; Strain EC
    J Pharmacol Exp Ther; 2014 Feb; 348(2):217-26. PubMed ID: 24227768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Breast feeding during methadon- and buprenorphin therapy].
    Müller MJ; Lange M; Paul T; Seeliger S
    Klin Padiatr; 2011 Dec; 223(7):408-13. PubMed ID: 21969026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.